Genetic Foresight
- Business Model
- B2B
- Total Funding
- $17.6M
- Last Round
- $17.6M Series BAug 2020
- Rounds
- 1
About
Pharmacogenomics platform helping clinicians prevent adverse drug reactions by ranking treatment options based on patient genetics.
Summary
Genetic Foresight is a Biotech company. It has raised $17.6M in total across 1 round, most recently a $17.6M Series B round in Aug 2020. Investors include Polaris Partners and SkyDeck Berkeley.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2020
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...